Tag: InterMune Inc

  • NASDAQ New Highs: Zillow Inc (NASDAQ:Z), Kraft Foods Group (NASDAQ:KRFT), InterMune Inc (NASDAQ:ITMN), Questcor Pharmaceuticals Inc (NASDAQ:QCOR), Pernix Therapeutics Holdings (NASDAQ:PTX)

    Zillow Inc (NASDAQ:Z), announced introducing the Zestimate Forecast. This is a special tool which allows users to calculate the future value of homes. This is said to be the first-of-its-kind consumer-based predictive tool for estimating the true value of a home. Zillow Inc (NASDAQ:Z), net profit margin is -6.70% and weekly performance is 11.62%. On last trading day company shares ended up $114.32. Analysts mean target price for the company is $103.43. Zillow Inc (NASDAQ:Z), distance from 50-day simple moving average (SMA50) is 18.71%.

    On May 19, 2014, Kraft Foods Group Inc (NASDAQ:KRFT), has issued a recall of 1.2 million cases of cottage cheese after certain ingredients were not stored at a safe temperature at a manufacturing plant in Tulare, California. Kraft Foods Group Inc (NASDAQ:KRFT), advanced 0.21% in last trading session and ended the day on $57.83. KRFT, Gross Margin is 39.20% and its return on assets is 11.90%. Kraft Foods Group Inc (NASDAQ:KRFT), quarterly performance is 5.94%.

    On May 20, 2014, InterMune Inc (NASDAQ:ITMN), announced that results of analyses of pooled data from the ASCEND trial and the two previous Phase 3 CAPACITY trials evaluating pirfenidone in patients with idiopathic pulmonary fibrosis (IPF) were presented at the 2014 International Conference of the American Thoracic Society (ATS) in San Diego, Calif. InterMune Inc (NASDAQ:ITMN), shares moved up 1.62% in last trading session and was closed at $39.46, while trading in range of $38.81 – 40.00. InterMune Inc (NASDAQ:ITMN), year to date (YTD) performance is 167.89%.

    On May 21, 2014, The drug maker Questcor Pharmaceuticals Inc (NASDAQ:QCOR), just got over a major hurdle in its efforts to merge into a fellow drug company. The U.S. Federal Trade Commission announced the termination of the antitrust review of the deal between Questcor and Mallinckrodt PLC (NYSE:MNK). The development gives the companies an opportunity to face their respective shareholders with confidence. Questcor Pharmaceuticals Inc (NASDAQ:QCOR), ended the last trading day at $92.05. Company weekly volatility is calculated as 3.13% and price to cash ratio as 11.61. Questcor Pharmaceuticals Inc (NASDAQ:QCOR), showed a negative weekly performance of 20.77%.

    Pernix Therapeutics Holdings Inc (NASDAQ:PTX), major shareholder James Edward Jr. Smith unloaded 194,600 shares of the company’s stock on the open market in a transaction dated Wednesday, May 21st. The stock was sold at an average price of $6.13, for a total value of $1,192,898.00. Following the completion of the sale, the insider now directly owns 3,498,504 shares in the company, valued at approximately $21,445,830. Pernix Therapeutics Holdings Inc (NASDAQ:PTX), net profit margin is -33.00% and weekly performance is 0.16%. On last trading day company shares ended up $6.44. Analysts mean target price for the company is $6.33. Pernix Therapeutics Holdings Inc (NASDAQ:PTX), distance from 50-day simple moving average (SMA50) is 29.84%.